Integer (NYSE:ITGR) Issues FY 2026 Earnings Guidance

Integer (NYSE:ITGR) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 5.830-6.400 for the period, compared to the consensus EPS estimate of 6.490. The company issued revenue guidance of $1.8 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

Integer Trading Down 5.4%

ITGR stock opened at $83.69 on Friday. The firm’s 50-day moving average is $86.07 and its 200 day moving average is $81.76. The company has a market capitalization of $2.85 billion, a PE ratio of 29.16, a P/E/G ratio of 1.50 and a beta of 0.71. Integer has a 12 month low of $62.00 and a 12 month high of $126.86. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.23.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The company had revenue of $439.58 million for the quarter, compared to analysts’ expectations of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the business posted $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, research analysts anticipate that Integer will post 6.47 EPS for the current year.

Wall Street Analyst Weigh In

ITGR has been the topic of a number of research analyst reports. Wells Fargo & Company boosted their target price on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Citigroup lowered their target price on Integer from $92.00 to $89.00 and set a “neutral” rating on the stock in a report on Friday. Truist Financial raised their price target on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Piper Sandler reissued an “overweight” rating and issued a $97.00 price objective (up from $87.00) on shares of Integer in a research report on Friday. Finally, Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Four research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $98.29.

Insider Activity

In other news, VP Tommy P. Thomas sold 825 shares of the business’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the transaction, the vice president directly owned 4,381 shares of the company’s stock, valued at approximately $372,385. The trade was a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.10% of the stock is owned by corporate insiders.

Trending Headlines about Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Piper Sandler reaffirmed an “overweight” rating and raised its price target to $97, signaling upside potential and institutional confidence in Integer’s longer?term prospects. Piper Sandler Rating
• Positive Sentiment: Integer’s board initiated a strategic review (including potential sale, merger or other combinations) to maximize shareholder value — a catalyst that can unlock premium bids or strategic alternatives over time. Integer Strategic Review
• Positive Sentiment: Market commentary highlighted that revenue beat and strength across key product lines drove a positive market reaction despite an EPS miss, supporting confidence in top-line momentum. Zacks Coverage
• Neutral Sentiment: Several analysts updated forecasts after the Q1 release; revisions are mixed and reflect differing views on margin recovery and the impact of the strategic review. Analyst Revisions
• Neutral Sentiment: Trading in ITGR was briefly halted as news was released, which can increase intraday volatility but does not change fundamentals. Q1 Results Release
• Negative Sentiment: Q1 EPS was $1.20, missing consensus by $0.01 and down from $1.31 a year ago; management set FY26 EPS guidance of $5.83–$6.40, below the street consensus (~$6.49), which raises near?term execution concerns. Earnings Details
• Negative Sentiment: Citigroup trimmed its price target from $92 to $89 and moved to a “neutral” rating, reflecting more cautious near?term sentiment and limiting upside from that broker’s client base. Citigroup Note

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Integer by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock valued at $2,539,000 after purchasing an additional 837 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Integer by 2,408.8% in the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock valued at $14,531,000 after buying an additional 118,224 shares during the period. Jones Financial Companies Lllp boosted its stake in Integer by 79,888.9% in the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock valued at $850,000 after acquiring an additional 7,190 shares during the period. United Services Automobile Association acquired a new stake in shares of Integer in the 1st quarter worth about $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock valued at $12,900,000 after purchasing an additional 4,873 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.